tiprankstipranks
Mcpherson'S Limited (AU:MCP)
ASX:MCP

Mcpherson'S Limited (MCP) AI Stock Analysis

5 Followers

Top Page

AU:MCP

Mcpherson'S Limited

(Sydney:MCP)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 5.2)
Rating:46Neutral
Price Target:
AU$0.17
▼(-30.42% Downside)
Action:ReiteratedDate:11/18/25
The overall stock score is primarily impacted by financial performance challenges, including persistent profitability issues and cash flow concerns. Technical analysis indicates a bearish trend, and valuation metrics are weak due to a negative P/E ratio and lack of dividend yield. The absence of earnings call data and corporate events means these factors did not influence the score.
Positive Factors
Revenue Growth Momentum
A 24.14% uplift in the latest reported period and ~20% revenue growth metric indicate expanding product demand and stronger wholesale/retail sell-through. Durable top-line expansion supports scale benefits, strengthens negotiation leverage with retailers and suppliers, and underpins medium-term recovery of margins if sustained.
Negative Factors
Persistent Negative Profitability
Ongoing negative net profit and operating margins show the business has structural cost or operating inefficiencies that erode returns despite revenue growth. Until operating leverage is realized or cost bases reset, sustained losses will constrain reinvestment, dividends and investor confidence over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth Momentum
A 24.14% uplift in the latest reported period and ~20% revenue growth metric indicate expanding product demand and stronger wholesale/retail sell-through. Durable top-line expansion supports scale benefits, strengthens negotiation leverage with retailers and suppliers, and underpins medium-term recovery of margins if sustained.
Read all positive factors

Mcpherson'S Limited (MCP) vs. iShares MSCI Australia ETF (EWA)

Mcpherson'S Limited Business Overview & Revenue Model

Company Description
McPherson's Limited provides health, wellness, and beauty products in Australia, New Zealand, Asia, and internationally. It offers beauty care, hair care, skin care, and personal care items, including facial wipes, cotton pads, and foot comfort pr...
How the Company Makes Money
McPherson's makes money primarily by selling consumer health, beauty and wellness products into wholesale and retail channels. Revenue is generated from (1) sales of branded products the company owns or manages (brand development, marketing and ca...

Mcpherson'S Limited Financial Statement Overview

Summary
Mcpherson's Limited shows mixed financial health with strong revenue growth but persistent profitability issues. The balance sheet reflects improved leverage but negative returns on equity. Cash flow challenges persist, with declining free cash flow and low cash conversion ratios, indicating potential liquidity concerns.
Income Statement
45
Neutral
Balance Sheet
55
Neutral
Cash Flow
40
Negative
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue134.24M138.99M144.63M155.23M214.00M200.50M
Gross Profit62.31M80.45M35.09M47.77M90.80M87.48M
EBITDA-6.83M-6.99M-4.92M3.10M7.44M5.98M
Net Income-16.42M-15.04M-15.99M-5.06M333.00K-5.37M
Balance Sheet
Total Assets116.49M117.21M146.90M190.06M215.76M199.59M
Cash, Cash Equivalents and Short-Term Investments12.74M9.48M24.77M7.03M13.14M7.35M
Total Debt7.07M7.30M19.85M25.45M29.38M20.93M
Total Liabilities45.97M44.23M57.26M80.61M94.95M84.96M
Stockholders Equity70.52M72.98M89.64M109.45M120.81M114.62M
Cash Flow
Free Cash Flow6.08M1.57M9.64M4.70M16.32M168.00K
Operating Cash Flow6.31M2.21M12.34M6.55M18.57M2.69M
Investing Cash Flow-1.85M-3.62M16.29M-1.85M-2.25M-31.80M
Financing Cash Flow-3.54M-13.91M-10.90M-10.91M-10.59M29.42M

Mcpherson'S Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.24
Price Trends
50DMA
0.19
Negative
100DMA
0.21
Negative
200DMA
0.24
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
36.80
Neutral
STOCH
33.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:MCP, the sentiment is Negative. The current price of 0.24 is above the 20-day moving average (MA) of 0.18, above the 50-day MA of 0.19, and below the 200-day MA of 0.24, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 36.80 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:MCP.

Mcpherson'S Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
AU$29.03M21.2514.06%1.54%6.89%607.27%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
59
Neutral
AU$34.76M157.840.80%1.58%-65.09%
46
Neutral
AU$24.47M-3.77-22.89%-3.91%5.94%
46
Neutral
AU$34.66M-3.00-16.89%2.35%95.03%
45
Neutral
AU$15.00M-0.262542.90%12.92%34.21%
44
Neutral
AU$5.80M-5.68-10.69%-25.16%77.62%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:MCP
Mcpherson'S Limited
0.17
-0.08
-33.33%
AU:PTL
Pental Ltd.
0.03
-0.03
-48.48%
AU:ABY
Adore Beauty Group Ltd.
0.37
-0.37
-50.00%
AU:SKN
Skin Elements Limited
AU:CCX
City Chic Collective Limited
0.09
-0.03
-25.00%
AU:S66
Star Combo Pharma Ltd.
0.22
0.05
34.37%

Mcpherson'S Limited Corporate Events

McPherson’s Expands On-Market Buy-Back With Fresh Daily Purchases
Mar 30, 2026
McPherson’s Limited has continued its on-market share buy-back program, reporting a cumulative 1,440,317 ordinary fully paid shares repurchased prior to the latest trading day. On the previous day alone, the company bought back an additional...
McPherson’s Updates Market on Progress of On-Market Share Buy-Back
Mar 29, 2026
McPherson’s Limited has continued its on-market share buy-back program, reporting that a total of 1,350,317 ordinary fully paid shares had been repurchased before the previous trading day. The company disclosed that it bought back a further ...
Microequities Exits Substantial Holder Position in McPherson’s Limited
Mar 26, 2026
Microequities Asset Management has lodged a notice with the ASX advising that it has ceased to be a substantial holder in McPherson’s Limited. The filing indicates that Microequities’ voting interest in McPherson’s has fallen bel...
McPherson’s Updates Market on Progress of On-Market Share Buy-Back
Mar 25, 2026
McPherson’s Limited has provided an updated notification to the ASX regarding its on-market share buy-back of ordinary fully paid shares under code MCP. The company continues to execute its approved buy-back program, indicating active capita...
McPherson’s Updates Market on Progress of On‑Market Share Buy‑Back
Mar 18, 2026
McPherson’s Limited has provided an updated notification to the ASX regarding its on-market share buy-back program for ordinary fully paid shares. The company reported that a cumulative 480,317 shares had been repurchased before the previous...
McPherson’s details flexible on-market share buy-back activity
Mar 16, 2026
McPherson’s Limited has lodged a daily notification with the ASX outlining activity under its on-market share buy-back program for its ordinary fully paid shares, identified under code MCP, as at 17 March 2026. The company currently has 143,...
McPherson’s Launches Flexible On‑Market Share Buy‑Back
Mar 12, 2026
McPherson’s Limited has lodged a daily notification with the ASX confirming it is conducting an on‑market share buy‑back of its ordinary fully paid shares. The buy‑back applies to a total on‑issue capital of 143,949,1...
McPherson’s Unveils $2 Million On-Market Share Buy-Back as Part of Capital Management Drive
Feb 25, 2026
McPherson’s Limited, a Sydney-based ASX-listed supplier of health and beauty products under brands such as Manicare, Swisspers and Dr. LeWinn’s, targets consumers through pharmacy, grocery, health food and online retail channels. The c...
McPherson’s Sets Webcast to Present 1H26 Financial Results
Feb 25, 2026
McPherson’s Limited, a Sydney-based ASX-listed supplier of health and beauty products built around brands such as Manicare, Swisspers, Lady Jayne, Dr. LeWinn’s and Fusion Health, targets consumers via pharmacy, grocery, health food and...
McPherson’s trims costs, lifts cash as new operating model beds down despite 1H loss
Feb 25, 2026
McPherson’s reported revenue from continuing operations of $66.0 million for the half year to 31 December 2025, a 6.7% decline, but maintained largely stable core brand sales at $61.9 million as Manicare and Swisspers delivered solid growth ...
McPherson’s Announces Departure of Director Jane McKellar and Discloses Final Shareholding
Feb 1, 2026
McPherson’s Limited has announced the cessation of director Jane Matisse McKellar from the company’s board effective 31 January 2026, in accordance with ASX listing rule disclosure requirements. At the time of her departure, McKellar h...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 18, 2025